SG Americas Securities’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-23,128
Closed -$125K 3162
2020
Q2
$125K Buy
23,128
+7,886
+52% +$41.8K ﹤0.01% 3220
2020
Q1
$57K Buy
+15,242
New +$79.3K ﹤0.01% 3158
2017
Q3
Sell
-61,930
Closed -$326K 3646
2017
Q2
$326K Buy
61,930
+29,153
+89% +$163K ﹤0.01% 2122
2017
Q1
$196K Buy
32,777
+18,977
+138% +$114K ﹤0.01% 2451
2016
Q4
$83K Buy
+13,800
New +$97.2K ﹤0.01% 2895
2016
Q2
Sell
-15,100
Closed -$111K 2848
2016
Q1
$111K Buy
+15,100
New +$74.8K ﹤0.01% 2569

Other funds holding MNOV

SG Americas Securities's MNOV Position: Q3 2020 in Review

SG Americas Securities sold out of MediciNova (MNOV) in Q3 2020, closing a stake of 23,128 shares — an estimated $125K sold.

SG Americas Securities first reported a position in MNOV in Q1 2016 and held it in 6 quarters. The position peaked at $326K in Q2 2017. 53 funds tracked by Wall St. Rank hold MNOV as of Q3 2020.

  • SG Americas Securities reported no remaining MediciNova position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 23,128 MediciNova shares in Q3 2020, an estimated $125K.
  • SG Americas Securities first reported a position in MediciNova in Q1 2016 and held it in 6 quarters.
  • SG Americas Securities's MediciNova position peaked at $326K in Q2 2017.
  • 53 funds tracked by Wall St. Rank held MediciNova as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.